Lataa...
The Use of Low-Dose Intermittent Levosimendan Infusion Therapy as Bridge-to-Left Ventricular Assist Device in Advanced Chronic Heart Failure Secondary to Isolated Cardiac Sarcoidosis
Heart failure (HF) is a progressive condition that usually involves a debilitating late course with poor health-related quality of life and increasing mortality rate. In this report, we demonstrate the efficacy and safety of intermittent levosimendan infusion as a bridging therapy to left ventricula...
Tallennettuna:
| Julkaisussa: | Heart Views |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer - Medknow
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8104322/ https://ncbi.nlm.nih.gov/pubmed/33986931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_85_20 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|